Literature DB >> 11710830

Identification and characterization of a novel human hepatocellular carcinoma-associated gene.

Z X Wang1, H Y Wang, M C Wu.   

Abstract

To investigate liver cancer-associated genes and to explore the molecular basis of liver cancer genesis, we have cloned a novel hepatocellular carcinoma (HCC)-related gene with a transcript of 2520 base pairs in length named HCCA2 by mRNA differential display polymerase chain reaction (DDPCR) and screening a placenta cDNA library. No significant homologous protein with known genes was found. Western blot analysis showed that HCCA2 could be expressed in transfected 293 cells. Northern hybridization analysis showed that HCCA2 mRNA was expressed in 79% (34/43) patients with HCC, most of whom had significantly high expression in HCC tissues, while not expressed in corresponding noncancerous liver tissues. The clinical pathological data showed that the HCCA2 was significantly associated with the invasion of tumour capsule (P = 0.0007) and the expression of ki-67 protein (P = 0.0022). Immunohistochemical staining confirmed that the HCCA2 protein was localized in cytoplasm of liver cancer tissues. According to amino acid analysis of the protein and its localization, it may play a role in a cascade of intracellular signal transduction because the protein was characterized with two Src homology 3 (SH3) binding-domains and several functional motifs of phosphorylation. Copyright 2001 Cancer Research Campaign http://www.bjcancer.com.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710830      PMCID: PMC2375167          DOI: 10.1054/bjoc.2001.2059

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

Review 1.  Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events.

Authors:  A M Hui; M Makuuchi
Journal:  Scand J Gastroenterol       Date:  1999-08       Impact factor: 2.423

Review 2.  Protein phosphorylation and signal transduction.

Authors:  J D Graves; E G Krebs
Journal:  Pharmacol Ther       Date:  1999 May-Jun       Impact factor: 12.310

3.  Differential expression of MAM-subfamily protein tyrosine phosphatases during mouse development.

Authors:  M Fuchs; H Wang; T Ciossek; Z Chen; A Ullrich
Journal:  Mech Dev       Date:  1998-01       Impact factor: 1.882

4.  Identification of a novel gene, LDOC1, down-regulated in cancer cell lines.

Authors:  K Nagasaki; T Manabe; H Hanzawa; N Maass; T Tsukada; K Yamaguchi
Journal:  Cancer Lett       Date:  1999-06-01       Impact factor: 8.679

5.  SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55.

Authors:  H Kang; C Freund; J S Duke-Cohan; A Musacchio; G Wagner; C E Rudd
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

6.  Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Authors:  N Kondoh; T Wakatsuki; A Ryo; A Hada; T Aihara; S Horiuchi; N Goseki; O Matsubara; K Takenaka; M Shichita; K Tanaka; M Shuda; M Yamamoto
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

Review 7.  Genetic aspects of hepatocellular carcinogenesis.

Authors:  M Ozturk
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

8.  Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study.

Authors:  D G Tiniakos; E M Brunt
Journal:  Liver       Date:  1999-02

Review 9.  [Epidemiology and diagnosis of hepatocellular carcinomas in cirrhosis].

Authors:  C Duvoux
Journal:  Ann Chir       Date:  1998

10.  Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia.

Authors:  T Schlott; K Ahrens; I Ruschenburg; S Reimer; H Hartmann; M Droese
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  5 in total

1.  Gene-expression signature of vascular invasion in hepatocellular carcinoma.

Authors:  Beatriz Mínguez; Yujin Hoshida; Augusto Villanueva; Sara Toffanin; Laia Cabellos; Swan Thung; John Mandeli; Daniela Sia; Craig April; Jian-Bing Fan; Anja Lachenmayer; Radoslav Savic; Sasan Roayaie; Vincenzo Mazzaferro; Jordi Bruix; Myron Schwartz; Scott L Friedman; Josep M Llovet
Journal:  J Hepatol       Date:  2011-04-13       Impact factor: 25.083

Review 2.  MOB control: reviewing a conserved family of kinase regulators.

Authors:  Alexander Hergovich
Journal:  Cell Signal       Date:  2011-04-21       Impact factor: 4.315

3.  The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma.

Authors:  X-W Wan; M Jiang; H-F Cao; Y-Q He; S-Q Liu; X-H Qiu; M-C Wu; H-Y Wang
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-07       Impact factor: 4.553

4.  Hepatocellular carcinoma-associated gene 2 interacts with MAD2L2.

Authors:  Li Li; Yan Shi; Huiling Wu; Bingbing Wan; Pu Li; Li Zhou; Huili Shi; Keke Huo
Journal:  Mol Cell Biochem       Date:  2007-06-01       Impact factor: 3.396

Review 5.  MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer.

Authors:  Ramazan Gundogdu; Alexander Hergovich
Journal:  Cells       Date:  2019-06-10       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.